Pharma Pulse 3/15/24: Elranatamab Maintains or Improves Symptoms of Multiple Myeloma Patients, AI Assistant for Security Products & more

Benefits and Limitations of Strategies Used to Improve Clinical Development Productivity

In this Pharmaceutical Executive video interview, Murray Aitken, Executive Director of the IQVIA Institute for Human Data Science, discusses findings from IQVIA's Global Trends in R&D 2024 report including the potential benefits and limitations of novel trial designs and decentralized methodologies.

Elranatamab Maintains or Improves Symptoms and Health Status of Patients With Multiple Myeloma

This finding was evident in both examined groups and regardless of the patients' B-cell maturation antigen-directed therapy status.

Pharma dealt a loss over drug discount program

Pharmaceutical interests lost a closely watched battle over the federal drug discount program on Tuesday when a federal appeals court ruled that Arkansas can block manufacturers from limiting the availability of discounted drugs at certain pharmacies.

Microsoft to Launch AI Assistant for Security Products

Tech giant says Copilot for Security will be available worldwide next month under a pay-as-you-go licensing model

@FujifilmDiosyn on Twitter/X:

We are delighted to introduce our Partners for Life Strategy, outlining our strategic priorities – People First, Transforming the Industry and Unprecedented Delivery. Read more:

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs